EQL Pharma

49,80 SEK

+5,29%

Mindre end 1K følgere

EQL

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Værdiansættelse

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for EQL Pharma

P/E

Medianen 2019-2025

EV/S

Medianen 2019-2025

EV/EBIT

Medianen 2019-2025

P/B

Medianen 2019-2025

 
2019202020212022202320242025
Aktiekurs (SEK)12,0513,4035,1031,0037,4042,3071,00
Aktier29,129,129,129,129,129,129,1
Markedsværdi350,2389,41.020,1901,01.087,01.229,42.063,5
Enterprise value328,5379,3994,9859,81.109,21.329,02.432,7
EV/S6,65,35,62,14,35,06,5
EV/EBITDA97,452,086,922,126,840,736,1
EV/EBITneg.120,286,922,126,840,736,1
P/Eneg.143,998,228,434,354,248,0
P/B4,484,8111,177,297,026,929,34
P/S7,05,45,72,24,24,75,5
Udbytteprocent0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %
Equity ratio76,6 %65,1 %45,9 %52,0 %54,2 %47,6 %27,3 %
Gearing ratio----43,1 %67,6 %204,3 %